全球人口篩檢市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計人口篩檢市場將從 2025 年的 355.8 億美元成長到 2034 年的 592.5 億美元，2026 年至 2034 年的複合年成長率為 5.83%。

隨著各國政府和醫療機構日益重視疾病早期發現和預防性醫療保健，全球人口篩檢市場持續穩定成長。人們對癌症、糖尿病和心血管疾病等慢性病的認知不斷提高，推動了大規模篩檢計畫的需求。許多國家正在投資國家級篩檢計劃，旨在降低長期醫療成本並提高存活率。診斷工具和數位醫療系統的技術進步也為都市區地區的篩檢流程提供了更快、更準確的支援。

文明病和遺傳性疾病在全球日益加重，是推動市場成長要素之一。人口老化，尤其是在已開發國家，進一步推動了人們對定期健康檢查的需求。醫療服務可近性的提高、保險覆蓋範圍的擴大以及政府對公共衛生宣傳活動的投入，都增強了市場活力。此外，人工智慧和數據分析技術在篩檢專案中的應用，正在改善風險評估和個人化醫療，從而提高篩檢的有效性和可靠性。

未來幾年，隨著家用篩檢盒和行動醫療設備的推出，市場預計將進一步擴張。新興經濟體隨著醫療基礎設施的改善，可望迎來強勁的成長機會。數位化平台和遠端醫療將使偏遠地區的人們更容易獲得篩檢服務。隨著預防醫學成為全球優先事項，人群篩檢市場將持續創新並維持長期穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球人口篩檢市場：依產品分類

• 市場分析、洞察與預測
• 硬體設備（設備、套件、晶片）
• 檢測/實驗室（服務）
• 分析/解釋（個人化和解釋）

第5章：全球人口篩檢市場：依業務類型分類

• 市場分析、洞察與預測
• 醫院
• 研究機構
• 診斷檢查室

第6章：全球人口篩檢市場：依性別分類

• 市場分析、洞察與預測
• 男性
• 女士

第7章 全球人口篩檢市場：按類型分類

• 市場分析、洞察與預測
• 大量的
• 優質的

第8章：全球人口篩檢市場：依年齡層別分類

• 市場分析、洞察與預測
• 按年齡
• 15-65歲
• 65歲或以上

第9章 全球人口篩檢市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics
  • Illumina Inc
  • ARUP Laboratories
  • Novogene Co. Ltd
  • LGC Limited
  • Gene By Gene Ltd

The Population Screening Market size is expected to reach USD 59.25 Billion in 2034 from USD 35.58 Billion (2025) growing at a CAGR of 5.83% during 2026-2034.

The Global Population Screening Market is growing steadily as governments and healthcare organizations focus more on early disease detection and preventive healthcare. Rising awareness about chronic diseases such as cancer, diabetes, and cardiovascular disorders is driving demand for large-scale screening programs. Many countries are investing in national screening initiatives to reduce long-term healthcare costs and improve survival rates. Technological advancements in diagnostic tools and digital health systems are also supporting faster and more accurate screening processes across urban and rural areas.

One of the main growth drivers is the increasing burden of lifestyle-related and genetic diseases worldwide. Aging populations, especially in developed countries, are further boosting the demand for regular health screening programs. Improved access to healthcare services, expansion of insurance coverage, and government funding for public health campaigns are strengthening the market. Additionally, the integration of AI and data analytics in screening programs is enhancing risk assessment and personalized care, making screening more effective and reliable.

In the coming years, the market is expected to expand further with the adoption of home-based screening kits and mobile health units. Emerging economies are likely to offer strong growth opportunities as healthcare infrastructure improves. Digital platforms and telemedicine will make screening services more accessible to remote populations. As preventive healthcare becomes a global priority, the population screening market is set to witness continuous innovation and long-term sustainable growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Business

• Hospitals
• Research Institutes
• Diagnostic Labs

By Gender

• Male
• Female

By Type

• Mass
• Premium

By Age

• Ages
• 15-65
• Ages 65+

COMPANIES PROFILED

• Agilent Technologies Inc, Thermo Fisher Scientific Inc, QIAGEN, F HoffmannLa Roche Ltd, Quest Diagnostics, Illumina Inc, ARUP Laboratories, Novogene Co Ltd, LGC Limited, Gene by Gene Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POPULATION SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POPULATION SCREENING MARKET: BY BUSINESS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Business
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POPULATION SCREENING MARKET: BY GENDER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Gender
• 6.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POPULATION SCREENING MARKET: BY TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Type
• 7.2. Mass Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Premium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL POPULATION SCREENING MARKET: BY AGE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Age
• 8.2. Ages
• 8.3. 15-65 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Ages 65+ Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL POPULATION SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Business
  • 9.2.3 By Gender
  • 9.2.4 By Type
  • 9.2.5 By Age
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Business
  • 9.3.3 By Gender
  • 9.3.4 By Type
  • 9.3.5 By Age
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Business
  • 9.4.3 By Gender
  • 9.4.4 By Type
  • 9.4.5 By Age
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Business
  • 9.5.3 By Gender
  • 9.5.4 By Type
  • 9.5.5 By Age
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Business
  • 9.6.3 By Gender
  • 9.6.4 By Type
  • 9.6.5 By Age
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL POPULATION SCREENING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Thermo Fisher Scientific Inc
  • 11.2.3 QIAGEN
  • 11.2.4 F. Hoffmann-La Roche Ltd
  • 11.2.5 Quest Diagnostics
  • 11.2.6 Illumina Inc
  • 11.2.7 ARUP Laboratories
  • 11.2.8 Novogene Co. Ltd
  • 11.2.9 LGC Limited
  • 11.2.10 Gene By Gene Ltd